cnbc.com / .cnbc-com-health-care

Trump suggested that those levies would not go into effect immediately, saying he will "give people about a year, year and a half"

Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.

The bill would cut $1.1 trillion in health-care spending and result in 11.8 million people losing health coverage over the next decade, according to estimates.

The phase three study data clears the path forward for Moderna's combination jab targeting Covid-19 and influenza.

The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

It is unclear how Kennedy's new members, including Dr. Robert Malone, will affect the panel's vaccine recommendations.

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.

Insurers such as CVS and UnitedHealthcare will implement the changes across commercial, Medicare and Medicaid plans, benefiting 257 million Americans.